<![CDATA[Teva Pharmaceutical Industries Ltd. 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=24765>Fri, 15 May 2026 00:28:01 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[테바, ‘아조비’ 일본 임상시험의 긍정적인 중요 결과 발표]]>https://www.newswire.co.kr/newsRead.php?no=900768Tue, 04 Feb 2020 11:46:41 +0900<![CDATA[Teva Announces Positive Top-Line Results from AJOVY® (fremanezumab) Clinical Trials in Japan]]>https://www.newswire.co.kr/newsRead.php?no=900767Tue, 04 Feb 2020 11:41:36 +0900<![CDATA[Teva Provides Additional Detail on Proposed Acquisition of Mylan]]>https://www.newswire.co.kr/newsRead.php?no=790966Wed, 06 May 2015 16:55:00 +0900<![CDATA[테바, 밀란 인수 제안에 추가적인 세부사항 공개]]>https://www.newswire.co.kr/newsRead.php?no=790967Wed, 06 May 2015 16:55:00 +0900<![CDATA[Teva Sends Letter to Mylan Board]]>https://www.newswire.co.kr/newsRead.php?no=790658Fri, 01 May 2015 12:00:00 +0900<![CDATA[테바, 밀란 이사회에 서한 송부]]>https://www.newswire.co.kr/newsRead.php?no=790659Fri, 01 May 2015 12:00:00 +0900<![CDATA[Teva Reiterates Commitment to Cash-and-Stock Acquisition of Mylan for $82.00 Per Share]]>https://www.newswire.co.kr/newsRead.php?no=790263Tue, 28 Apr 2015 13:55:00 +0900<![CDATA[테바, 밀란에 주당 82달러 현금 및 주식 인수 반복 제안]]>https://www.newswire.co.kr/newsRead.php?no=790264Tue, 28 Apr 2015 13:55:00 +0900<![CDATA[Teva Files for Hart-Scott-Rodino Notification Regarding Proposed Acquisition of Mylan]]>https://www.newswire.co.kr/newsRead.php?no=789743Thu, 23 Apr 2015 10:10:00 +0900<![CDATA[테바, 밀란 인수 제안 관련 하트-스콧-로디노 신고 제출]]>https://www.newswire.co.kr/newsRead.php?no=789746Thu, 23 Apr 2015 10:10:00 +0900<![CDATA[Teva Proposes to Acquire Mylan for $82.00 Per Share in Cash and Stock]]>https://www.newswire.co.kr/newsRead.php?no=789735Thu, 23 Apr 2015 09:55:00 +0900<![CDATA[테바, 주당 82달러에 밀란 인수 제안···현금과 주식으로 지급]]>https://www.newswire.co.kr/newsRead.php?no=789738Thu, 23 Apr 2015 09:55:00 +0900